Seminars in Nuclear Medicine

Papers
(The TQCC of Seminars in Nuclear Medicine is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Limitations and Pitfalls of FDG-PET/CT in Infection and Inflammation78
Artificial Intelligence and Machine Learning in Nuclear Medicine: Future Perspectives69
Academic integrity and artificial intelligence: is ChatGPT hype, hero or heresy?68
Application of Deep Learning in Breast Cancer Imaging66
Imaging of Head and Neck Cancer With CT, MRI, and US59
Imaging of COVID-19: CT, MRI, and PET51
Brain [F-18]FDG PET for Clinical Dementia Workup: Differential Diagnosis of Alzheimer's Disease and Other Types of Dementing Disorders50
Imaging of Tumor Hypoxia for Radiotherapy: Current Status and Future Directions44
Ethical and Legal Challenges of Artificial Intelligence in Nuclear Medicine43
Intelligent Imaging in Nuclear Medicine: the Principles of Artificial Intelligence, Machine Learning and Deep Learning42
Recent Developments in SPECT/CT41
[18F]FDG-PET/CT Radiomics and Artificial Intelligence in Lung Cancer: Technical Aspects and Potential Clinical Applications37
Clinical Management of COVID-19 Patients – An Update34
PET/MR in Head and Neck Cancer – An Update34
Radiomics in PET/CT: Current Status and Future AI-Based Evolutions33
Advances in Brain Amyloid Imaging33
A role of FDG-PET/CT for response evaluation in metastatic breast cancer?31
Artificial Intelligence for Optimization and Interpretation of PET/CT and PET/MR Images31
FDG-PET/CT for Primary Staging and Detection of Recurrence of Breast Cancer30
Imaging of Tau Pathology in Neurodegenerative Diseases: An Update29
Sentinel Lymph Node Methods in Breast Cancer28
FDG-PET/CT of COVID-19 and Other Lung Infections28
Variants and Pitfalls in PET/CT Imaging of Gastrointestinal Cancers27
Coronavirus Disease 2019 (COVID-19) in Molecular Imaging: A Systematic Review of Incidental Detection of SARS-CoV-2 Pneumonia on PET Studies27
16α-18F-fluoro-17β-Fluoroestradiol (FES): Clinical Applications for Patients With Breast Cancer26
Imaging for Response Assessment in Cancer Clinical Trials26
FDG PET/CT for Assessment of Immune Therapy: Opportunities and Understanding Pitfalls26
FAPI-avid nonmalignant PET/CT findings: An expedited systematic review26
Lymphoscintigraphy for Sentinel Node Mapping in Head and Neck Cancer25
PET Agents in Dementia: An Overview24
Hyperpolarized MRI – An Update and Future Perspectives24
Social Asymmetry, Artificial Intelligence and the Medical Imaging Landscape23
Radiation Dosimetry in 177Lu-PSMA-617 Therapy23
Clinical Use of PET/MR in Oncology: An Update23
PET/CT in Bladder Cancer: An Update23
PET/CT in Non-Hodgkin Lymphoma: An Update22
Total-body PET/CT – First Clinical Experiences and Future Perspectives22
Digital PET vs Analog PET: Clinical Implications?22
Imaging for Target Delineation in Head and Neck Cancer Radiotherapy21
PET/CT Variants and Pitfalls in Gynecological Cancers20
How to Design AI-Driven Clinical Trials in Nuclear Medicine20
Radiation Safety and Accidental Radiation Exposures in Nuclear Medicine20
PET-CT for Staging and Detection of Recurrence of Head and Neck Cancer19
PET/CT Variants and Pitfalls in Prostate Cancer: What You Might See on PET and Should Never Forget18
PET Imaging in Neurodegeneration and Neuro-oncology: Variants and Pitfalls18
Measurement of Glomerular Filtration Rate18
FDG PET/CT for Evaluation of Immunotherapy Response in Lung Cancer Patients17
Artificial Intelligence for the Characterization of Pulmonary Nodules, Lung Tumors and Mediastinal Nodes on PET/CT17
PET/CT in Surgical Planning for Head and Neck Cancer17
PET/CT Variants and Pitfalls in Bone and Soft Tissue Sarcoma17
Advancement in Production of Radiotracers17
Current Status and Future Perspective on Molecular Imaging and Treatment of Neuroblastoma16
Radiation Dose Modulation of Computed Tomography Component in Positron Emission Tomography/Computed Tomography16
Parametric Imaging With Dynamic PET for Oncological Applications: Protocols, Interpretation, Current Applications and Limitations for Clinical Use16
The Impact of Radiopharmaceutical Therapy on Renal Function16
A Role for FDG PET Radiomics in Personalized Medicine?15
PET/CT in Hodgkin Lymphoma: An Update15
Advances in PET/CT Technology: An Update15
Hybrid Imaging of Vascular Cognitive Impairment14
Artificial Intelligence for Response Evaluation With PET/CT14
Molecular Imaging of Fever of Unknown Origin: An Update14
Diagnosis and Image-guided Therapy of Cardiac Left Ventricular Assist Device Infections14
Multimodality Imaging and Artificial Intelligence for Tumor Characterization: Current Status and Future Perspective13
PET/CT Variants and Pitfalls in Breast Cancers13
Pediatric Nephro-Urology: Overview and Updates in Diuretic Renal Scans and Renal Cortical Scintigraphy13
Preclinical Development in Radiopharmaceutical Therapy for Prostate Cancer13
Advancement and Future Perspective of FAPI PET/CT In Gynecological Malignancies13
A Role of PET/MR in Breast Cancer?13
The Value of the Standardized Uptake Value (SUV) and Metabolic Tumor Volume (MTV) in Lung Cancer13
18F-FDG PET/CT for Evaluation of Post-Transplant Lymphoproliferative Disorder (PTLD)12
PET/MR Technology: Advancement and Challenges12
SPECT and PET Radiotracers in Renal Imaging12
Role of Non-FDG-PET/CT in Head and Neck Cancer12
Mediastinal Masses: 18F-FDG-PET/CT Features Based on the International Thymic Malignancy Interest Group Classification12
Quantitative SPECT/CT for Dosimetry of Peptide Receptor Radionuclide Therapy12
PSMA PET/CT for Primary Staging of Prostate Cancer - An Updated Overview12
Update on Management of Medullary Thyroid Carcinoma: Focus on Nuclear Medicine12
Histopathologically Validated Diagnostic Accuracy of PSMA-PET/CT in the Primary and Secondary Staging of Prostate Cancer and the Impact of PSMA-PET/CT on Clinical Management: A Systematic Review and M12
0.025470018386841